why choose us

First received: September 13, 2023

Clinical Trial: A Study of Omaveloxolone in Children With Friedreich's Ataxia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Friedreich Ataxia

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Single-Dose Of Omaveloxolone In Children ?2 To <16 Years Of Age With Friedreich's Ataxia

Brief Summary: This is an open-label study evaluating the safety, tolerability, and PK following single-dose administration of omaveloxolone in pediatric patients with FA.The study will consist of 3 parts (Parts A, B, and C) based on age.

Read more